CN1017901B - 抗精神病药稠环吡啶基哌嗪衍生物的制备方法 - Google Patents
抗精神病药稠环吡啶基哌嗪衍生物的制备方法Info
- Publication number
- CN1017901B CN1017901B CN86103071A CN86103071A CN1017901B CN 1017901 B CN1017901 B CN 1017901B CN 86103071 A CN86103071 A CN 86103071A CN 86103071 A CN86103071 A CN 86103071A CN 1017901 B CN1017901 B CN 1017901B
- Authority
- CN
- China
- Prior art keywords
- compound
- chinese style
- formula
- butyl
- piperazinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 91105826 CN1021631C (zh) | 1985-05-06 | 1991-08-19 | 含稠环吡啶基哌嗪衍生物的抗精神病药的制备方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73120185A | 1985-05-06 | 1985-05-06 | |
US731,201 | 1985-05-06 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 91105826 Division CN1021631C (zh) | 1985-05-06 | 1991-08-19 | 含稠环吡啶基哌嗪衍生物的抗精神病药的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN86103071A CN86103071A (zh) | 1987-03-18 |
CN1017901B true CN1017901B (zh) | 1992-08-19 |
Family
ID=24938510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN86103071A Expired CN1017901B (zh) | 1985-05-06 | 1986-05-05 | 抗精神病药稠环吡啶基哌嗪衍生物的制备方法 |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPH0753728B2 (fr) |
KR (1) | KR940000829B1 (fr) |
CN (1) | CN1017901B (fr) |
AT (1) | AT398572B (fr) |
AU (1) | AU593244B2 (fr) |
BE (1) | BE904724A (fr) |
CA (1) | CA1278792C (fr) |
CH (1) | CH672787A5 (fr) |
DE (1) | DE3615180C2 (fr) |
DK (1) | DK165745C (fr) |
EG (1) | EG18206A (fr) |
ES (6) | ES8801250A1 (fr) |
FI (1) | FI85484C (fr) |
FR (1) | FR2581385B1 (fr) |
GB (1) | GB2174703B (fr) |
GR (1) | GR861149B (fr) |
HU (1) | HU195509B (fr) |
IE (1) | IE59201B1 (fr) |
IT (1) | IT1208607B (fr) |
LU (1) | LU86421A1 (fr) |
MY (1) | MY100777A (fr) |
NL (1) | NL8601146A (fr) |
PT (1) | PT82523B (fr) |
SE (1) | SE465270B (fr) |
ZA (1) | ZA862046B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801186A (en) | 1987-11-20 | 1998-09-01 | Hoechst Marion Roussel, Inc. | 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds |
US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
US4780466A (en) * | 1988-03-17 | 1988-10-25 | Hoechst-Roussel Pharmaceuticals, Inc. | Arylpiperazinylalkoxy derivatives of cyclic imides |
IE903410A1 (en) * | 1989-10-09 | 1991-04-10 | Novo Nordisk As | Indole derivatives, their preparation and use |
US5272148A (en) * | 1992-09-09 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Heteroarenylpiperazines |
BR9610579A (pt) * | 1995-09-15 | 1999-07-06 | Sanofi Synthelabo | Derivados de quinolein-2(1H)-ona como antagonistas da serotonina |
FR2738822B1 (fr) * | 1995-09-15 | 1997-10-31 | Synthelabo | Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique |
FR2738824B1 (fr) * | 1995-09-15 | 1997-10-31 | Synthelabo | Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique |
FR2738823B1 (fr) * | 1995-09-15 | 1997-10-31 | Synthelabo | Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique |
FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
FR2797874B1 (fr) * | 1999-08-27 | 2002-03-29 | Adir | Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4367335A (en) * | 1981-08-03 | 1983-01-04 | Mead Johnson & Company | Thiazolidinylalkylene piperazine derivatives |
US4452799A (en) * | 1981-12-23 | 1984-06-05 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
US4361565A (en) * | 1981-12-28 | 1982-11-30 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines |
-
1986
- 1986-03-11 CA CA000503794A patent/CA1278792C/fr not_active Expired - Fee Related
- 1986-03-19 ZA ZA862046A patent/ZA862046B/xx unknown
- 1986-04-29 AU AU56795/86A patent/AU593244B2/en not_active Expired
- 1986-04-29 GR GR861149A patent/GR861149B/el unknown
- 1986-04-29 EG EG250/86A patent/EG18206A/xx active
- 1986-04-30 FI FI861820A patent/FI85484C/fi not_active IP Right Cessation
- 1986-05-02 GB GB08610810A patent/GB2174703B/en not_active Expired
- 1986-05-02 KR KR1019860003445A patent/KR940000829B1/ko not_active IP Right Cessation
- 1986-05-05 NL NL8601146A patent/NL8601146A/nl active Search and Examination
- 1986-05-05 ES ES554659A patent/ES8801250A1/es not_active Expired
- 1986-05-05 CH CH1830/86A patent/CH672787A5/de not_active IP Right Cessation
- 1986-05-05 SE SE8602061A patent/SE465270B/sv not_active IP Right Cessation
- 1986-05-05 BE BE0/216623A patent/BE904724A/fr not_active IP Right Cessation
- 1986-05-05 FR FR8606471A patent/FR2581385B1/fr not_active Expired - Lifetime
- 1986-05-05 CN CN86103071A patent/CN1017901B/zh not_active Expired
- 1986-05-05 DE DE3615180A patent/DE3615180C2/de not_active Expired - Lifetime
- 1986-05-05 IE IE119386A patent/IE59201B1/en not_active IP Right Cessation
- 1986-05-05 LU LU86421A patent/LU86421A1/fr unknown
- 1986-05-05 DK DK207186A patent/DK165745C/da not_active IP Right Cessation
- 1986-05-06 PT PT82523A patent/PT82523B/pt unknown
- 1986-05-06 JP JP61103726A patent/JPH0753728B2/ja not_active Expired - Lifetime
- 1986-05-06 IT IT8620313A patent/IT1208607B/it active
- 1986-05-06 HU HU861860A patent/HU195509B/hu unknown
- 1986-05-06 AT AT0121486A patent/AT398572B/de not_active IP Right Cessation
-
1987
- 1987-09-25 ES ES557757A patent/ES8802149A1/es not_active Expired
- 1987-10-01 MY MYPI87002712A patent/MY100777A/en unknown
-
1988
- 1988-01-28 ES ES557809A patent/ES8802614A1/es not_active Expired
- 1988-05-26 ES ES557839A patent/ES8900138A1/es not_active Expired
- 1988-11-16 ES ES557855A patent/ES8900253A1/es not_active Expired
-
1989
- 1989-02-27 ES ES557865A patent/ES9000005A1/es not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1036920C (zh) | 含杂环碳酸衍生物 | |
CN1036652C (zh) | 碱式季酰胺,其制备方法及其药物组合物 | |
CN1254474C (zh) | 作为多巴胺D<sub>3</sub>受体调节剂(精神抑制药)的四氢苯并氮杂䓬衍生物 | |
JP6422986B2 (ja) | 化合物 | |
CN1169808C (zh) | β-咔啉化合物 | |
CN1426411A (zh) | 3-(二芳基亚甲基)-8-氮杂双环[3.2.1]辛烷衍生物 | |
CN1934091A (zh) | 治疗神经变性障碍的咪唑化合物 | |
CN1524080A (zh) | 作为pde4抑制剂的2,3-二氮杂萘酮哌啶子基衍生物 | |
CN101052618A (zh) | 用作治疗阿尔茨海默氏病的β-分泌酶抑制剂的2-氨基吡啶化合物 | |
CN1098098A (zh) | 哌嗪衍生物 | |
CN1056879A (zh) | 吡咯衍生物及其制备方法 | |
CN1426398A (zh) | 稠合杂芳基衍生物 | |
CN1753672A (zh) | 作为cb-1配体的4,5-二芳基噻唑衍生物 | |
CN1059210C (zh) | 制备6-杂环-4-氨基-1,3,4,5-四氢苯并[cd]吲哚及其可作药用的酸加成盐的方法 | |
CN1468224A (zh) | 用作α-2拮抗剂的喹啉衍生物 | |
CN1871242A (zh) | 作为mch r1拮抗剂用于治疗肥胖症、糖尿病、抑郁症和焦虑的3-(4-(氨基苯基)噻吩并嘧啶-4-酮衍生物 | |
KR20070091007A (ko) | 인데닐 유도체 및 신경계 장애의 치료를 위한 이들의 용도 | |
CN1452623A (zh) | 新的4-苯基取代的四氢异喹啉类化合物及其治疗用途 | |
CN86102349A (zh) | 制备n-[(4-哌啶基)烷基]取代的双环稠合的唑与噻唑胺之方法 | |
CN1585752A (zh) | 4,4-二氟-1,2,3,4-四氢-5h-1-苯并氮杂䓬衍生物或其盐 | |
CN1768055A (zh) | 作为代谢型谷氨酸受体-5调制剂的四环咪唑衍生物 | |
CN1794990A (zh) | 代谢型谷氨酸受体-5的二芳基取代吡咯调节剂 | |
CN1017901B (zh) | 抗精神病药稠环吡啶基哌嗪衍生物的制备方法 | |
CN1798744A (zh) | 作为nmda/nr2b拮抗剂的3-氟-哌啶化合物 | |
CN1111528C (zh) | 用作神经激肽拮抗药的哌嗪衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C13 | Decision | ||
GR02 | Examined patent application | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |